Tokyo, June 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058295) titled 'Gene editing of human immune cell-derived iPS cells and production of immune cells' on June 26.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - RIKEN
Condition:
Condition - Gene editing of human immune cell-derived iPS cells and production of immune cells
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - The efficacy of cell product will be evaluated using immune cells from healthy donors.
Basic objectives2 - Efficacy
Interventi...